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Abstract
Background: Few prospective studies have attempted to estimate the rate of decline of essential tremor (ET) and these were over a relatively short time period (less
than 10 years). We performed a long-term study of severity stages in ET using the Glass Scale scoring system.
Methods: Fifty consecutive patients with severe ET were included. We retrospectively obtained Glass Scale scores throughout the patient’s life. Common
milestone events were used to help recall changes in tremor severity.
Results: According to the Glass Scale, the age distributions were as follows: score I, 40¡17 years, score II, 55¡12 years, score III, 64¡9 years, and score IV,
69¡7 years. A significant negative correlation between age at first symptom and rate of progression was found (r520.669, p,0.001). The rate of progression was
significantly different (p,0.001) when the first symptom appeared at a younger age (under 40 years of age) compared with older age (40 years or older).
Discussion: Our results support the progressive nature of ET. Age at onset was a prognostic factor. The Glass Scale may be a useful tool to determine severity
stages during the course of ET in a manner similar to the Hoehn and Yahr Scale for Parkinson’s disease.
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Introduction
Essential tremor (ET) is generally considered to be a neurodegen-
erative disease.1,2 Prospective and longitudinal data have shown a
progressive worsening in tremor scores over time. The average annual
increase in tremor severity from baseline has been estimated to be
between 3.1% and 5.3%. Nevertheless, to our knowledge, only four
studies have attempted to estimate the rate of decline over time and
they have all been performed over a relatively short period (less than
10 years).3–6
The Glass Scale was developed as a simple tool to measure the
severity of ET in everyday clinical practice.7 It is simple to use and
quick to administer to ET patients with upper limb involvement (95%
of patients). This scale has only four scores and its characteristics are
similar to those of the Hoehn and Yahr Scale, the classical stage
marker of Parkinson’s disease.8
In this article, we used the Glass Scale to assess severity staging of
ET using a retrospective method, which permitted a long-term
evaluation. We hypothesized that the study could help to confirm the
progressive nature of the disorder and to determine prognostic factors.
It could also elucidate the usefulness of the Glass Scale as a marker of
ET stage.
Methods
Fifty consecutive patients with severe ET (Glass Scale score III or
higher) attending the Movement Disorders Unit at Sant Pau
Neurology Department from January 2012 to September 2014 were
included in the study (27 males, 23 females; mean age 72.5 years,
range 60–79 years).
Diagnosis of ET was established using the consensus criteria
established by the Movement Disorders Society.9 All the patients
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fulfilled neurophysiological criteria for ET.10 The study protocol was
approved by the Hospital Ethics Committee and was performed in
accordance with international ethical regulations. All subjects received
and signed informed consent to participate.
The Glass Scale score is obtained by asking the patient a single
question: ‘‘When you are seated at the table, how do you drink water
from a glass with your dominant hand?’’7 By means of extensive
interviews with the patients and their relatives, we retrospectively
obtained Glass Scale scores throughout the patient’s life. We asked
when they first noted tremor in their arms (Glass Scale I), when tremor
increased, making it difficult to drink from a glass using one hand
(Glass Scale II), when tremor provoked the need to use both hands to
drink (Glass Scale III), and when patients needed a straw to drink
(Glass Scale IV). We used common milestone events to help to
remember tremor severity changes, such as school leaving age, age of
military service in the case of men, marriage, birth, or wedding of a
child, and retirement. To simplify data collection, we did not include
the second part (A and B) of the scale.
The two most reliable scores were I (symptoms first noticed) and III
(when both hands were first needed to drink from a glass). Scores II
and IV are more difficult to obtain precisely. For this reason, we used
the time lapse between scores I and III to correlate disease progression
rate and clinical predictors.
We assessed several clinical factors, on the basis of a chart review
and on the patient’s report, to correlate with ET worsening over time
that could predict the rate of change: age at first symptom, gender,
years of education, baseline head tremor, baseline voice tremor, family
history of ET, baseline asymmetrical tremor, usual caffeine intake,
tremoric drugs, and ET medications.
Statistical analysis
We initially performed a descriptive analysis. Categorical variables
were reported as percentage and number of cases. Quantitative
variables were presented as the mean¡standard deviation. We studied
the possible relationship between quantitative variables and the time
lapse between Glass Scale scores I and III using Pearson’s correlation
coefficient. When of interest, we added a scatterplot for easier
understanding, and we used a box-plot for some variables. The
Student t-test was used to compare quantitative variables in the two
groups.
In all analysis, the statistical level of significance was established at
5% (alpha50.05, two-sided). The statistical package used was IBM-
SPSS (V 22.0).
Results
Fourteen patients were classified as Glass Scale score IV, and 36 as
score III. Table 1 shows the demographic and clinical characteristics
of the patients in our series. We found the following age distribution
according to the Glass Scale scores: score I 40¡17 years, score II
55¡12 years, score III 64¡9 years, and score IV 69¡7 years
(Figure 1). The mean time in years to reach each score was: score II
17¡10, score III 25¡13, and score IV 36¡15 years (Figure 1).
We found a significant negative correlation between age at first
symptom of ET (Glass Scale score I) and time between scores I and III
(r520.669, p,0.0001) (Figure 2).
No significant correlation was found between the other clinical
variables studied and time between scores I and III: gender
(p50.092), years of education (p50.990), baseline head tremor
(p50.238), baseline voice tremor (p50.358), family history of ET
(p50.097), baseline asymmetrical tremor (p50.809), usual caffeine
intake (p50.888), tremoric drugs (p50.768), and ET medications
(p50.766).
We repeated the statistical analysis using two group of patients:
patients in whom symptoms of ET first appeared before 40 years of
age (n519; 9 females; mean age of onset520¡7 years), and patients in
whom they appear at 40 years or older (n531; 14 females; mean age of
onset 52¡7 years). We found that patients who presented tremor at a
younger age took 37¡10 years to reach stage III, while patients with
debut at an older age took 17¡8 years. This difference was statistically
significant (p,0.0001) (Figure 3).
Discussion
In this retrospective study covering a wide time span, we found that
ET was a slow, progressive disorder, and that the rate of progression
depended on the age of disease onset. The progressive course of the
disease is in concordance with the four previous prospective studies.
Elble3 followed 44 ET patients over 4 years using accelerometry and
found a 7.4% yearly worsening after baseline. Putzke et al.4
prospectively analyzed 45 patients with a mean follow-up of 3.6 years.
Table 1. Demographic and Clinical Characteristic of Essential Tremor
Patients.
Characteristics Data
Age (years) 72.5¡12.4
Female gender 23 (46)
Education (years) 15.2¡2.0
Age at first symptom 40.1¡17.1
Tremor duration (years) 27.1¡7.7
Baseline asymmetry 1 (2)
Baseline head tremor 26 (52)
Baseline voice tremor 11 (22)
Family history of ET 44 (88)
Takes daily caffeine 5 (10)
Takes daily tremoric drugs 7 (14)
Takes daily antitremoric drugs 50 (100)
Abbreviation: ET, Essential Tremor.
Values represent mean¡SD or number (percentage).
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They estimated a 12% annual worsening in clinical tremor ratings
after baseline. In another study, Louis et al.5 followed 83 patients for a
mean of 5 years and found an average annual increase in tremor
severity from baseline between 3.1% and 5.3%. The most recent
longitudinal study, by Louis et al.,6 had a mean follow-up of 5.8 years
and was performed in 116 patients. The authors used the spirography
test to quantify tremor and found worsening of spiral score at an
average rate of 0.12 points per year.
Figure 1. Glass Scale Scores and Age (years) of Patients in the Present Series. X axis: The Glass Scale; Y axis: Age (years).
Figure 2. Correlation between Glass Scale Score I (age at first symptom) and Time Between Scores I and III (r520.669, p,0.0001). X axis: The Glass Scale; Y axis:
Age (years).
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Studies on ET progression are difficult because they require a very
long follow-up. Prospective studies reported to date had a relatively
short follow-up, of 3–6 years. The Glass Scale assessment, however,
does not imply the need for a clinical evaluation in person and is based
solely on anamnesis of the patient and/or relatives. This point,
together with the scale’s simplicity, makes it suitable for retrospective
studies. Another strength of the Glass Scale is that it is not susceptible
to intra-subject variability as it collects data referring to a period of
time rather than to a single assessment as when using presential clinical
rating scales or accelerometry.
We consider ET to be a progressive disorder with several stages of
severity. The Glass Scale may be useful in determining these levels.
The Glass Scale score I corresponds to a mild severity stage when the
patient may need occasional medication. Score II corresponds to a
moderate severity stage, during which patients commonly need
continuous drug therapy. Scores III and IV correspond to high
severity stages when the patient often needs polytherapy and surgery.
However, ET has a great clinical heterogeneity. Interestingly, in about
20–30% of patients, tremor did not worsen in longitudinal studies,
although the follow-up periods were short. Louis et al. performed an
interesting cross-sectional study of ET in 335 patients to determine the
clinical situation of the disease at each 10-year milestone.11 Each
patient underwent a single evaluation of tremor severity. They found
that after more than 40 years of ET duration, 20–60% of patients had
a high tremor amplitude. Less than 10% of patients were
incapacitated. The authors concluded that there is a progressive
decade-by-decade decline in ET. However, patients with long disease
duration did not converge at the same end-stage of severe functionally
incapacitating tremor.
Clinical baseline predictors of worsening in ET have been analyzed
in some previous prospective studies. Putzke et al.4 found the
asymmetrical self-reported tremor onset and asymmetrical tremor
ratings at the first clinic visit to be significant predictive factors. In our
study, only one of the patients recounted an asymmetrical onset. Louis
et al. found no baseline factors that predicted annual change in ET.5 In
their second study, they found statistically significant differences in the
rate of progression between familial and non-familial ET. The rate of
change was higher in ET patients with a family history.6 In our study,
we did not find a significant correlation with this variable, although the
series was biased as most ET patients in our series had a family history.
Interestingly, in our study we found a clear relationship between age
at onset of the disease and rate of progression. We agree with the
results of a previous retrospective study by Louis et al.12 In that study,
the rate of progression was estimated based on the tremor severity and
reported disease duration at the time of evaluation. They found that
patients with age of onset after 60 years progressed more rapidly.
Furthermore, this finding is similar to other neurodegenerative
disorders such as Parkinson’s disease.13 In fact, older age at onset is
a poor prognosis marker and has a major progression rate.
The study has several limitations that make our estimates more
conservative. The main limitation of our study is that it is retrospective
and is subject to recall bias and low precision of data: the patient can
remember approximate but not exact dates at which the severity of
tremor changes. Another limitation is that although the Glass Scale has
displayed a strong construct validity compared with the Tremor
Clinical Rating Scale (weighted kappa50.907) and high inter-rater
validity (weighted kappa50.937), several psychometric properties,
such as floor and ceiling effects, are not known.7 Moreover, it is only a
Figure 3. Rate of Progression to Reach Glass Scale Score III (p,0.0001) when Disease Begins Before 40 Years of Age (continuous line) and at 40 Years or Older
(discontinuous line). X axis: The Glass Scale; Y axis: Age (years).
Gironell A, Ribosa-Nogue´ R, Gich I, et al. Severity Stages in Essential Tremor
Tremor and Other Hyperkinetic Movements
http://www.tremorjournal.org
The Center for Digital Research and Scholarship
Columbia University Libraries/Information Services4
four-point scale, and, thus, lacks precision for a more fine-grained
analysis of rate of progression. Another limitation is that the patients
were enrolled in a clinic-based study. It has been described that there is
a substantial difference between clinic and community ET cases in
terms of the information they provide regarding their family history,
thus affecting their estimate of rate of progression.14 Finally, our
sample of ET patients is biased for several clinical variables, thus
limiting predictive analysis.
In conclusion, our study supports the progressive nature of ET. Age
at onset of symptoms is a prognostic factor. If tremor begins before 40
years of age, the rate of progression is low. Finally, the Glass Scale may
be a useful tool to determine severity stages during the course of ET, in
a similar way to the Hoehn and Yahr Scale for Parkinson’s disease.
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